- Home
- Publications
- Publication Search
- Publication Details
Title
Drugging the Cancers Addicted to DNA Repair
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 109, Issue 11, Pages -
Publisher
Oxford University Press (OUP)
Online
2017-03-18
DOI
10.1093/jnci/djx059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery
- (2017) Juhong Jiang et al. INVESTIGATIONAL NEW DRUGS
- 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
- (2017) Parker L. Sulkowski et al. Science Translational Medicine
- Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germlineBRCA1/2mutation: a multistudy analysis of response rates and safety
- (2016) U. A. Matulonis et al. ANNALS OF ONCOLOGY
- Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway
- (2016) David Lopez-Martinez et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
- (2016) M. L. Telli et al. CLINICAL CANCER RESEARCH
- Mechanism and regulation of DNA end resection in eukaryotes
- (2016) Lorraine S. Symington CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors
- (2016) Fong W. Liu et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- DNA polymerase θ (POLQ), double-strand break repair, and cancer
- (2016) Richard D. Wood et al. DNA REPAIR
- Interplay between Fanconi anemia and homologous recombination pathways in genome integrity
- (2016) Johanna Michl et al. EMBO JOURNAL
- Evaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy
- (2016) Zachary B Jenner et al. Future Oncology
- New concepts on BARD1: Regulator of BRCA pathways and beyond
- (2016) Irmgard Irminger-Finger et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer
- (2016) Shivaani Kummar et al. INVESTIGATIONAL NEW DRUGS
- Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment
- (2016) Anselmo Papa et al. Journal of Translational Medicine
- Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin
- (2016) Carine Robert et al. LEUKEMIA RESEARCH
- TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation
- (2016) Younghyun Lee et al. MOLECULAR CANCER THERAPEUTICS
- Essential Roles for Polymerase θ-Mediated End Joining in the Repair of Chromosome Breaks
- (2016) David W. Wyatt et al. MOLECULAR CELL
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA repair targeted therapy: The past or future of cancer treatment?
- (2016) Navnath S. Gavande et al. PHARMACOLOGY & THERAPEUTICS
- Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection
- (2016) Katherine Sullivan et al. PLoS One
- Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency
- (2016) Kate S. Reid-Bayliss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining
- (2016) Younghyun Lee et al. RADIOTHERAPY AND ONCOLOGY
- DNA double-strand-break repair in higher eukaryotes and its role in genomic instability and cancer: Cell cycle and proliferation-dependent regulation
- (2016) Emil Mladenov et al. SEMINARS IN CANCER BIOLOGY
- Inherited PTEN mutations and the prediction of phenotype
- (2016) Nicholas R. Leslie et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Repair Pathway Choices and Consequences at the Double-Strand Break
- (2016) Raphael Ceccaldi et al. TRENDS IN CELL BIOLOGY
- Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells
- (2016) Sanjeevani Arora et al. Oncotarget
- Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
- (2016) Junko Murai et al. Oncotarget
- Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1 -Mutant Ovarian Cancer
- (2016) Young Eun Choi et al. Cell Reports
- Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells
- (2016) Sarah R Hengel et al. eLife
- Reappearance from Obscurity: Mammalian Rad52 in Homologous Recombination
- (2016) Kritika Hanamshet et al. Genes
- The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
- (2015) Michael Goldstein et al. Annual Review of Medicine
- Chemical inhibitor targeting the replication protein A–DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer
- (2015) Akaash K. Mishra et al. BIOCHEMICAL PHARMACOLOGY
- PARP inhibitors in the management of breast cancer: current data and future prospects
- (2015) Luca Livraghi et al. BMC Medicine
- Beyond BRCA: New hereditary breast cancer susceptibility genes
- (2015) P. Economopoulou et al. CANCER TREATMENT REVIEWS
- Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers
- (2015) Gurushankar Chandramouly et al. CHEMISTRY & BIOLOGY
- New insights into the mechanism of DNA mismatch repair
- (2015) Gloria X. Reyes et al. CHROMOSOMA
- FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
- (2015) G. Kim et al. CLINICAL CANCER RESEARCH
- Genetic testing forRAD51Cmutations: in the clinic and community
- (2015) V. Sopik et al. CLINICAL GENETICS
- Inhibition of the ERCC1–XPF structure-specific endonuclease to overcome cancer chemoresistance
- (2015) Ewan M. McNeil et al. DNA REPAIR
- Regulation of the Rev1-pol complex during bypass of a DNA interstrand cross-link
- (2015) M. Budzowska et al. EMBO JOURNAL
- A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation — An NRG Oncology/Gynecologic Oncology Group study
- (2015) Robert L. Coleman et al. GYNECOLOGIC ONCOLOGY
- Chromothripsis in cancer cells: An update
- (2015) Agata Rode et al. INTERNATIONAL JOURNAL OF CANCER
- A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix
- (2015) Charles Kunos et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemical Structure and Properties of Interstrand Cross-Links Formed by Reaction of Guanine Residues with Abasic Sites in Duplex DNA
- (2015) Michael J. Catalano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition
- (2015) D. A. Alagpulinsa et al. MOLECULAR CANCER THERAPEUTICS
- The TMPRSS2-ERG Gene Fusion Blocks XRCC4-Mediated Nonhomologous End-Joining Repair and Radiosensitizes Prostate Cancer Cells to PARP Inhibition
- (2015) P. Chatterjee et al. MOLECULAR CANCER THERAPEUTICS
- Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy
- (2015) Ukhyun Jo et al. MOLECULES AND CELLS
- Alternative end-joining repair pathways are the ultimate backup for abrogated classical non-homologous end-joining and homologous recombination repair: Implications for the formation of chromosome translocations
- (2015) George Iliakis et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Oxidatively induced DNA damage and its repair in cancer
- (2015) Miral Dizdaroglu MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair
- (2015) Raphael Ceccaldi et al. NATURE
- Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination
- (2015) Pedro A. Mateos-Gomez et al. NATURE
- REV7 counteracts DNA double-strand break resection and affects PARP inhibition
- (2015) Guotai Xu et al. NATURE
- Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
- (2015) Maria Teresa Esposito et al. NATURE MEDICINE
- DNA polymerase θ—a new target for synthetic lethality?
- (2015) David Killock Nature Reviews Clinical Oncology
- Poisoning Cancer Cells with Oxidized Nucleosides
- (2015) Thomas Helleday NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- NSC666715 and Its Analogs Inhibit Strand-Displacement Activity of DNA Polymerase β and Potentiate Temozolomide-Induced DNA Damage, Senescence and Apoptosis in Colorectal Cancer Cells
- (2015) Aruna S. Jaiswal et al. PLoS One
- Enzyme mechanism-based, oxidative DNA–protein cross-links formed with DNA polymerase β in vivo
- (2015) Jason L. Quiñones et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EEPD1 Rescues Stressed Replication Forks and Maintains Genome Stability by Promoting End Resection and Homologous Recombination Repair
- (2015) Yuehan Wu et al. PLoS Genetics
- The combination of Hsp90 inhibitor 17AAG and heavy-ion irradiation provides effective tumor control in human lung cancer cells
- (2015) Hirokazu Hirakawa et al. Cancer Medicine
- A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments
- (2015) Kareem N. Mohni et al. PLoS One
- PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma
- (2015) Jara Majuelos-Melguizo et al. Oncotarget
- Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy
- (2015) Rachel Abbotts et al. Oncotarget
- Human RecQ Helicases in DNA Repair, Recombination, and Replication
- (2014) Deborah L. Croteau et al. Annual Review of Biochemistry
- Exploring the roles of PALB2 at the crossroads of DNA repair and cancer
- (2014) Joris Pauty et al. BIOCHEMICAL JOURNAL
- Stress and DNA repair biology of the Fanconi anemia pathway
- (2014) S. Longerich et al. BLOOD
- Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy
- (2014) P. S. Hahnel et al. BLOOD
- Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer
- (2014) Leticia Moreira et al. CANCER
- Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors
- (2014) Jing Nie et al. CANCER LETTERS
- ATR Pathway Inhibition Is Synthetically Lethal in Cancer Cells with ERCC1 Deficiency
- (2014) K. N. Mohni et al. CANCER RESEARCH
- DNA Replication and Oncogene-Induced Replicative Stress
- (2014) Stephanie A. Hills et al. CURRENT BIOLOGY
- DNA-PK phosphorylation of RPA32 Ser4/Ser8 regulates replication stress checkpoint activation, fork restart, homologous recombination and mitotic catastrophe
- (2014) Amanda K. Ashley et al. DNA REPAIR
- Exploiting DNA mismatch repair deficiency as a therapeutic strategy
- (2014) Delphine Guillotin et al. EXPERIMENTAL CELL RESEARCH
- DNA replication stress: Causes, resolution and disease
- (2014) Abdelghani Mazouzi et al. EXPERIMENTAL CELL RESEARCH
- Targeting DNA repair pathways for cancer treatment: what’s new?
- (2014) Mark R Kelley et al. Future Oncology
- PTIP associates with Artemis to dictate DNA repair pathway choice
- (2014) Jiadong Wang et al. GENES & DEVELOPMENT
- Genomic analysis of primordial dwarfism reveals novel disease genes
- (2014) R. Shaheen et al. GENOME RESEARCH
- Targeting Histone Deacetylases for Cancer Therapy: From Molecular Mechanisms to Clinical Implications
- (2014) Zhiming Li et al. International Journal of Biological Sciences
- The DDN Catalytic Motif Is Required for Metnase Functions in Non-homologous End Joining (NHEJ) Repair and Replication Restart
- (2014) Hyun-Suk Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DNA Repair and Redox Activities and Inhibitors of Apurinic/Apyrimidinic Endonuclease 1/Redox Effector Factor 1 (APE1/Ref-1): A Comparative Analysis and Their Scope and Limitations toward Anticancer Drug Development
- (2014) Gagandeep Kaur et al. JOURNAL OF MEDICINAL CHEMISTRY
- Irreversible Inhibition of DNA Polymerase β by Small-Molecule Mimics of a DNA Lesion
- (2014) Dumitru Arian et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- 53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks
- (2014) J. M. Daley et al. MOLECULAR AND CELLULAR BIOLOGY
- The Use of Olaparib (AZD2281) Potentiates SN-38 Cytotoxicity in Colon Cancer Cells by Indirect Inhibition of Rad51-Mediated Repair of DNA Double-Strand Breaks
- (2014) M. Tahara et al. MOLECULAR CANCER THERAPEUTICS
- A selective USP1–UAF1 inhibitor links deubiquitination to DNA damage responses
- (2014) Qin Liang et al. Nature Chemical Biology
- Understanding nucleotide excision repair and its roles in cancer and ageing
- (2014) Jurgen A. Marteijn et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Sources of DNA Double-Strand Breaks and Models of Recombinational DNA Repair
- (2014) A. Mehta et al. Cold Spring Harbor Perspectives in Biology
- From Breaking Bad to Worse: Exploiting Homologous DNA Repair Deficiency in Cancer
- (2014) M. T. Hemann Cancer Discovery
- MUS81-EME2 Promotes Replication Fork Restart
- (2014) Alessandra Pepe et al. Cell Reports
- Abasic and Oxidized Abasic Site Reactivity in DNA: Enzyme Inhibition, Cross-Linking, and Nucleosome Catalyzed Reactions
- (2013) Marc M. Greenberg ACCOUNTS OF CHEMICAL RESEARCH
- Modernizing the Nonhomologous End-Joining Repertoire: Alternative and Classical NHEJ Share the Stage
- (2013) Ludovic Deriano et al. Annual Review of Genetics
- Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity
- (2013) I. Bajrami et al. CANCER RESEARCH
- DNA repair mechanisms in dividing and non-dividing cells
- (2013) Teruaki Iyama et al. DNA REPAIR
- Breast cancer genes: beyond BRCA1 and BRCA2
- (2013) Ana Vega Frontiers in Bioscience-Landmark
- Radiosensitization of human lung cancer cells by the novel purine-scaffold Hsp90 inhibitor, PU-H71
- (2013) TATSUYA SEGAWA et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- DNA-dependent Protein Kinase Regulates DNA End Resection in Concert with Mre11-Rad50-Nbs1 (MRN) and Ataxia Telangiectasia-mutated (ATM)
- (2013) Yi Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RIF1 Is Essential for 53BP1-Dependent Nonhomologous End Joining and Suppression of DNA Double-Strand Break Resection
- (2013) J. Ross Chapman et al. MOLECULAR CELL
- Mechanisms of resistance to therapies targeting BRCA-mutant cancers
- (2013) Christopher J Lord et al. NATURE MEDICINE
- JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1–mediated chromatin response to DNA breaks
- (2013) Sugiko Watanabe et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- DNA double-strand-break complexity levels and their possible contributions to the probability for error-prone processing and repair pathway choice
- (2013) A. Schipler et al. NUCLEIC ACIDS RESEARCH
- A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer
- (2013) S Postel-Vinay et al. ONCOGENE
- Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells
- (2013) L. N. Truong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
- (2013) H. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 53BP1 Regulates DSB Repair Using Rif1 to Control 5' End Resection
- (2013) M. Zimmermann et al. SCIENCE
- DNA Damage Response: Three Levels of DNA Repair Regulation
- (2013) B. M. Sirbu et al. Cold Spring Harbor Perspectives in Biology
- Mammalian Transcription-Coupled Excision Repair
- (2013) W. Vermeulen et al. Cold Spring Harbor Perspectives in Biology
- Nucleotide Excision Repair in Eukaryotes
- (2013) O. D. Scharer Cold Spring Harbor Perspectives in Biology
- DNA Double-Strand Break Repair as Determinant of Cellular Radiosensitivity to Killing and Target in Radiation Therapy
- (2013) Emil Mladenov et al. Frontiers in Oncology
- The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
- (2012) Mike De Vos et al. BIOCHEMICAL PHARMACOLOGY
- DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
- (2012) Wynand P. Roos et al. CANCER LETTERS
- PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells
- (2012) H. Cheng et al. CARCINOGENESIS
- Molecular Pathways: Understanding the Role of Rad52 in Homologous Recombination for Therapeutic Advancement
- (2012) B. H. Lok et al. CLINICAL CANCER RESEARCH
- On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
- (2012) X. Luo et al. GENES & DEVELOPMENT
- Inhibition of the Nedd8 System Sensitizes Cells to DNA Interstrand Cross-linking Agents
- (2012) Y. Kee et al. MOLECULAR CANCER RESEARCH
- Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress
- (2012) S. Liu et al. NUCLEIC ACIDS RESEARCH
- RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination
- (2012) B H Lok et al. ONCOGENE
- Synthetic Lethality of Cohesins with PARPs and Replication Fork Mediators
- (2012) Jessica L. McLellan et al. PLoS Genetics
- DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients
- (2012) C Allera-Moreau et al. Oncogenesis
- Repair of 3-methyladenine and abasic sites by base excision repair mediates glioblastoma resistance to temozolomide
- (2012) Michael S. Bobola et al. Frontiers in Oncology
- Synthetic lethality: exploiting the addiction of cancer to DNA repair
- (2011) M. Shaheen et al. BLOOD
- Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11
- (2011) Katharina Schlacher et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
- (2011) Junjun Chen et al. CHEMISTRY & BIOLOGY
- PARP-1 enhances the mismatch-dependence of 5′-directed excision in human mismatch repair in vitro
- (2011) Yiyong Liu et al. DNA REPAIR
- Repair of DNA damage induced by accelerated heavy ions-A mini review
- (2011) Ryuichi Okayasu INTERNATIONAL JOURNAL OF CANCER
- Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study
- (2011) Jens Samol et al. INVESTIGATIONAL NEW DRUGS
- MSH3 Mediates Sensitization of Colorectal Cancer Cells to Cisplatin, Oxaliplatin, and a Poly(ADP-ribose) Polymerase Inhibitor
- (2011) Masanobu Takahashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Irreversible Small Molecule Inhibitors of Replication Protein A Display Single-Agent Activity and Synergize with Cisplatin
- (2011) T. M. Neher et al. MOLECULAR CANCER THERAPEUTICS
- Heavy charged particle radiobiology: Using enhanced biological effectiveness and improved beam focusing to advance cancer therapy
- (2011) Christopher Allen et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Poly(ADP-ribose) polymerase and XPF–ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells
- (2011) Yong-Wei Zhang et al. NUCLEIC ACIDS RESEARCH
- More forks on the road to replication stress recovery
- (2011) C. Allen et al. Journal of Molecular Cell Biology
- Small-Molecule Inhibitors of APE1 DNA Repair Function: An Overview
- (2011) Rasha I. Al-Safi et al. Current Molecular Pharmacology
- Identification of Novel Small Molecule Inhibitors of the XPA Protein Usingin SilicoBased Screening
- (2010) Tracy M. Neher et al. ACS Chemical Biology
- Regulation of Homologous Recombination in Eukaryotes
- (2010) Wolf-Dietrich Heyer et al. Annual Review of Genetics
- DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1
- (2010) Sarah A. Martin et al. CANCER CELL
- Somatic Hypermethylation of MSH2 Is a Frequent Event in Lynch Syndrome Colorectal Cancers
- (2010) T. Nagasaka et al. CANCER RESEARCH
- Sensitivity to Poly(ADP-ribose) Polymerase (PARP) Inhibition Identifies Ubiquitin-specific Peptidase 11 (USP11) as a Regulator of DNA Double-strand Break Repair
- (2010) Timothy D. Wiltshire et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
- (2010) Svetlana Usanova et al. Molecular Cancer
- The DNA Damage Response: Making It Safe to Play with Knives
- (2010) Alberto Ciccia et al. MOLECULAR CELL
- Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4–ligase IV during chromosomal translocation formation
- (2010) Deniz Simsek et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
- (2010) Peter Bouwman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Metnase promotes restart and repair of stalled and collapsed replication forks
- (2010) Leyma P. De Haro et al. NUCLEIC ACIDS RESEARCH
- DNA polymerase up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability
- (2010) F. Lemee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-wide model for the normal eukaryotic DNA replication fork
- (2010) Andres A. Larrea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA Repair in Mammalian Cells
- (2009) T. Nouspikel CELLULAR AND MOLECULAR LIFE SCIENCES
- Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair geneMSH2
- (2009) Sarah A. Martin et al. EMBO Molecular Medicine
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- Cellular radiosensitivity: How much better do we understand it?
- (2009) Penny Jeggo et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- S-Phase Cells Are More Sensitive to High-Linear Energy Transfer Radiation
- (2009) Hongyan Wang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rad52 promotes second-end DNA capture in double-stranded break repair to form complement-stabilized joint molecules
- (2009) A. V. Nimonkar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Dealing with DNA Damage-Induced Replication Problems
- (2008) Magda Budzowska et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity
- (2008) Christopher J. Lord et al. DNA REPAIR
- DNA mismatch repair: Molecular mechanism, cancer, and ageing
- (2008) Peggy Hsieh et al. MECHANISMS OF AGEING AND DEVELOPMENT
- ERCC1-XPF Endonuclease Facilitates DNA Double-Strand Break Repair
- (2008) A. Ahmad et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search